We investigated whether ibrutinib protects against poly I:C- and LPS-induced ALI and established the significance of the BTK-, FLT3-, and EGFR-related signaling pathways in protecting against ALI. This evidence concerns the gene FLT3 and acute respiratory distress syndrome.